naloxone HCl

FDA Drug Profile — REZENOPY

naloxone HCl is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including REZENOPY. Available dosage form: spray.

Drug details

Generic Name
naloxone HCl
Brand Names
REZENOPY
Application Number
NDA215487
Sponsor
Scienture LLC
NDC Codes
1
Dosage Forms
SPRAY
Routes
NASAL
Active Ingredients
NALOXONE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE REZENOPY nasal spray is indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in adult and pediatric patients. REZENOPY nasal spray is intended for immediate administration as emergency therapy in settings where opioids may be present. REZENOPY nasal spray is not a substitute for emergency medical care. REZENOPY nasal spray is an opioid antagonist for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in adult and pediatric patients. ( 1 ) REZENOPY nasal spray is intended for immediate administration as emergency therapy in settings where opioids may be present. ( 1 ) REZENOPY nasal spray is not a substitute for emergency medical care. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.